Abstract
85
Acute myocardial infarction (AMI) and the heart failure which often ensues are one of the leading 86 causes of death and disability worldwide. For patients presenting with an AMI, the treatment of 87 choice is to restore coronary blood flow in the infarct-related artery, to salvage viable myocardium.
88
However, despite optimal therapy the morbidity and mortality of AMI patients remain significant with 89 7% death and 25% heart failure at one year [1] . The reason for this, is in part, due to the presence 90 of 'myocardial reperfusion injury' which refers to the myocardial injury and cardiomyocyte death, 91 that is paradoxically induced by myocardial reperfusion, and which can contribute up to 50% of the 92 final myocardial infarct (MI) size, and for which, there is currently no effective therapy [2] [3] . As 93 such, novel therapies are required to protect the heart against acute myocardial 94 ischaemia/reperfusion injury (IRI), in order to reduce MI size and prevent heart failure.
95
The inflammatory response to acute myocardial IRI plays a critical role in determining MI 
146
Methionine is oxidized to methionine sulfoxide (MetO) by the addition of an extra oxygen atom [27] .
147
The Anderson laboratory found that following initial Ca 2+ -dependent activation of CaMKII
148
(Ca 2+ /calmodulin-dependent kinase II), the specific oxidation of conserved Met 281/282 residues in 149 the regulatory domain could increase CaMKII activity independent of Ca 2+ /calmodulin [28] .
150
Substantial evidence has revealed that H2O2 production has been shown to be a major 
183
It may seem paradoxical that ROS are essential for promoting normal cellular processes, as 184 opposed to having a toxic effect on the heart. Even cell death that was previously thought to result 185 from oxidative damage is now considered to be the result of ROS triggering a physiological pathway 
257
XO has also been implicated in the leukocyte recruitment that occurs during reperfusion.
258
Leukocyte-endothelial cell adhesion in post-ischaemic models, and increased neutrophil adhesion 
279
The proposition that NOX enzymes contribute to acute myocardial IRI is based on two 
325
Mitochondrial complex I is viewed as a major contributor of ROS [11] . Oxidative impairment 
335
Complex III is also considered an important source for mitochondrial ROS production in 336 reperfused hearts. In the ischaemic heart, mitochondrial complex activity is reduced by 22% 
406
However, the most prominent cause of NOS uncoupling is the loss of the critical NOS co-factor, 
434
The presence of a higher glutathione peroxidase (GPx) activity is vital for the heart to 
444
The transcription factor Nrf2 is a master regulator of a spectrum of genes related to GSH 
457
Because of its ability to transfer electrons, it acts as an anti-oxidant. Q10 must be reduced to 
468
SOD is an enzyme that converts superoxide anion to hydrogen peroxide, which is 469 subsequently converted to water by catalase [138] . It protects against oxidative stress and has 
509
The production of ROS peaks during the first 2-10 minutes of reperfusion after coronary 510 artery occlusion and has been considered to be the first stimuli from neutrophils that invade the 
567
There is growing recognition and experimental evidence that oxidative stress-mediated and 
643
The phosphorylated form of GSK-3 correlates with the activity of cardioprotection. Via 
662
the inability to achieve sufficent concentrations of anti-oxidant at the site of ROS production.
663
Proteomic and metabolomic approaches may help in discover novel pathways underliyng the redox- 
